Mammalian Expression and Mass Spectrometric Characterization of Highly Active Human Arylsulfatase A哺乳动物表达及高效液相色谱-质谱表征高活性人芳基硫酸酯酶ABiotechnology JournalIF3.12026-09-290OAAI
Recent developments and future clinical prospects of polyclonal antibody therapiesEXPERT OPINION ON BIOLOGICAL THERAPYIF42025-12-010PRE
A rapid approach for linear epitope vaccine profiling reveals unexpected epitope tag immunogenicitySCIENTIFIC REPORTSIF3.92025-03-190OAAI
Red edge excitation shift spectroscopy is highly sensitive to tryptophan compositionJOURNAL OF THE ROYAL SOCIETY INTERFACEIF3.52023-11-083OAAI
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19CLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82023-08-113PRE
Mechanisms of host manipulation by Neisseria gonorrhoeae淋病奈瑟菌对宿主的调控机制FRONTIERS IN MICROBIOLOGYIF4.52023-02-0313OAAI
Deep mutational scanning for therapeutic antibody engineeringTRENDS IN PHARMACOLOGICAL SCIENCESIF19.92022-02-0124PRE
Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant DomainsFRONTIERS IN IMMUNOLOGYIF5.92020-08-1810OAAI
Molecular Design, Optimization, and Genomic Integration of Chimeric B Cell Receptors in Murine B CellsFRONTIERS IN IMMUNOLOGYIF5.92019-11-1427OAAI
High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesisNUCLEIC ACIDS RESEARCHIF13.12018-06-2159OAAI
Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchangeSCIENTIFIC REPORTSIF3.92017-04-0420OAAI
Immunogenomic engineering of a plug-and-(dis)play hybridoma platformNATURE COMMUNICATIONSIF15.72016-08-1747OAAI
High-resolution antibody dynamics of vaccine-induced immune responsesPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12014-03-17158OAAI
Effective Phagocytosis of Low Her2 Tumor Cell Lines with Engineered, Aglycosylated IgG Displaying High FcγRIIa Affinity and SelectivityACS CHEMICAL BIOLOGYIF3.82012-10-1165PREAI
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapyCURRENT OPINION IN BIOTECHNOLOGYIF72011-12-01105PREAI